TrialJAMA2025

Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial.

Mats C Højbjerg Lassen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.